Two Sigma Investments Portfolio holdings
AUM
$55.5B
1-Year Return
27.18%
This Quarter Return
-3.01%
1 Year Return
+27.18%
3 Year Return
+82.36%
5 Year Return
+135.75%
10 Year Return
+365.6%
AUM
$46B
AUM Growth
+$2.51B
(+5.8%)
Cap. Flow
+$2.44B
Cap. Flow
% of AUM
5.32%
Top 10 Holdings %
Top 10 Hldgs %
8.28%
Holding
3,576
New
447
Increased
1,213
Reduced
1,297
Closed
440
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$485M |
| 2 |
Broadcom
AVGO
|
+$251M |
| 3 |
Palantir
PLTR
|
+$233M |
| 4 |
Advanced Micro Devices
AMD
|
+$231M |
| 5 |
Salesforce
CRM
|
+$227M |
Top Sells
| 1 |
Progressive
PGR
|
+$264M |
| 2 |
Eli Lilly
LLY
|
+$254M |
| 3 |
Visa
V
|
+$246M |
| 4 |
Elevance Health
ELV
|
+$206M |
| 5 |
Intel
INTC
|
+$187M |
Sector Composition
| 1 | Technology | 18.19% |
| 2 | Healthcare | 13.46% |
| 3 | Financials | 10.58% |
| 4 | Industrials | 9.94% |
| 5 | Consumer Discretionary | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Myriad Genetics
MYGN
$715M
| $129K | ﹤0.01% |
+14,500
| New | +$129K |
|
2802
Hycroft Mining Holding Corp
HYMC
$244M
| $129K | ﹤0.01% |
39,665
+27,259
| +220% | +$88.3K |
|
|
ONL
2803
Orion Office REIT
ONL
$165M
| $128K | ﹤0.01% |
60,028
-97,197
| -62% | -$208K |
|
|
ARI
2804
Apollo Commercial Real Estate
ARI
$1.51B
| $127K | ﹤0.01% |
+13,313
| New | +$127K |
|
2805
Lexeo Therapeutics
LXEO
$277M
| $127K | ﹤0.01% |
+36,624
| New | +$127K |
|
2806
Neurogene
NGNE
$284M
| $127K | ﹤0.01% |
10,844
-9,785
| -47% | -$115K |
|
2807
TScan Therapeutics
TCRX
$101M
| $124K | ﹤0.01% |
+90,201
| New | +$124K |
|
|
FBLA
2808
FB Bancorp, Inc. Common Stock
FBLA
$222M
| $123K | ﹤0.01% |
+10,961
| New | +$123K |
|
2809
Rezolute
RZLT
$680M
| $123K | ﹤0.01% |
42,531
-16,932
| -28% | -$49.1K |
|
|
SIFY
2810
Sify Technologies
SIFY
$855M
| $123K | ﹤0.01% |
28,736
+5,960
| +26% | +$25.5K |
|
2811
Mission Produce
AVO
$890M
| $123K | ﹤0.01% |
11,715
-52,402
| -82% | -$549K |
|
|
SION
2812
Sionna Therapeutics, Inc. Common Stock
SION
$1.04B
| $123K | ﹤0.01% |
+11,715
| New | +$123K |
|
|
LAND
2813
Gladstone Land Corp
LAND
$319M
| $123K | ﹤0.01% |
+11,646
| New | +$123K |
|
2814
Zura Bio
ZURA
$132M
| $121K | ﹤0.01% |
94,055
-12,571
| -12% | -$16.2K |
|
2815
Inseego
INSG
$202M
| $121K | ﹤0.01% |
14,849
-18,102
| -55% | -$148K |
|
2816
Cosan
CSAN
$2.57B
| $118K | ﹤0.01% |
+22,649
| New | +$118K |
|
2817
Inovio Pharmaceuticals
INO
$134M
| $118K | ﹤0.01% |
+72,364
| New | +$118K |
|
2818
Liberty Latin America Class C
LILAK
$1.53B
| $117K | ﹤0.01% |
18,909
+4,609
| +32% | +$28.6K |
|
2819
indie Semiconductor
INDI
$760M
| $117K | ﹤0.01% |
57,368
-38,062
| -40% | -$77.5K |
|
|
OKUR
2820
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$32.7M
| $117K | ﹤0.01% |
+27,148
| New | +$117K |
|
|
AARD
2821
Aardvark Therapeutics, Inc. Common Stock
AARD
$173M
| $116K | ﹤0.01% |
+15,424
| New | +$116K |
|
2822
Mural Oncology
MURA
$36M
| $115K | ﹤0.01% |
91,624
+26,474
| +41% | +$33.4K |
|
2823
Latham Group
SWIM
$923M
| $114K | ﹤0.01% |
17,674
-14,804
| -46% | -$95.2K |
|
2824
Perimeter Solutions
PRM
$3.25B
| $113K | ﹤0.01% |
+11,222
| New | +$113K |
|
2825
Inotiv
NOTV
$50.2M
| $112K | ﹤0.01% |
50,684
-21,005
| -29% | -$46.4K |
|